NCT06075472

Brief Summary

The goal of this study is to investigate the effect of inspiratory muscle training (IMT) in Multiple Sclerosis (MS) patients on balance and postural control. The main question it aims to answer are: • Is IMT effective in improving balance and postural control in MS patients? Participants will be randomly divided into two groups. One group will be given only balance exercises. The other group will be given IMT treatment in addition to balance exercises.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at P25-P50 for not_applicable multiple-sclerosis

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

March 6, 2023

Completed
7 months until next milestone

First Posted

Study publicly available on registry

October 10, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 26, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 26, 2024

Completed
Last Updated

May 6, 2025

Status Verified

May 1, 2025

Enrollment Period

12 months

First QC Date

December 29, 2022

Last Update Submit

May 2, 2025

Conditions

Keywords

balanceinspiratory muscle trainingpostural control

Outcome Measures

Primary Outcomes (2)

  • Mini-BesTEST

    Mini-BESTest consists of 14 items divided into four subsections. In the Mini-BESTest evaluation, each item receives a three-point score. rated on an ordinal scale (0= lowest function ranging from level to 2= Normal function level). The total score is the sum of the scores obtained from these items. and ranges from 0 (worst) to 28 (best).

    Fifteen minutes

  • Trunk Impact Scale

    The Trunk Impact Scale (TIS) consists of three subscales: static sitting balance, dynamic sitting balance and co-ordination. Each subscale contains between three and ten items. The TIS score ranges from a minimum of 0 to a maximum of 23.

    Ten minutes

Secondary Outcomes (5)

  • Falls Efficacy Scale International

    Fifteen Minutes

  • Multiple Sclerosis Quality of Life-54 (MSQOL-54)

    Twenty minutes

  • Activities-Specific Balance Confidence Scale

    Ten Minutes

  • Two minutes walking test

    Four minutes

  • Pulmonary Function Test

    Ten minutes

Study Arms (2)

Treatment Group

EXPERIMENTAL

IMT: Inspiratory Muscle Training. Five days per week, 30 minutes per day.

Other: Inspiratory Muscle TrainingOther: Balance Exercises

Control Group

ACTIVE COMPARATOR

Balance exercises: It has been specially designed for the patient.

Other: Balance Exercises

Interventions

Inspiratory muscle training (IMT) is a therapeutic technique which involves specific training of respiratory muscles to yield improvements in inspiratory muscle strength and respiratory function.

Treatment Group

Balance exercises involve functional movements at the individual's maximum level of independence.

Control GroupTreatment Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having a diagnosis of relapsing-remitting MS with an EDSS of 1.5-5.5
  • Having a Mini Mental Test score greater than 24
  • Being between the ages of 18-65

You may not qualify if:

  • Having a neurological disease other than MS
  • Having an attack while working
  • Problems other than MS that may affect balance
  • Have a diagnosis of cardiac or pulmonary disease that will affect breathing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prof. Dr. Cemil Taşçıoğlu Şehir Hastanesi

Istanbul, Şişli, Turkey (Türkiye)

Location

Related Publications (4)

  • Martin-Sanchez C, Calvo-Arenillas JI, Barbero-Iglesias FJ, Fonseca E, Sanchez-Santos JM, Martin-Nogueras AM. Effects of 12-week inspiratory muscle training with low resistance in patients with multiple sclerosis: A non-randomised, double-blind, controlled trial. Mult Scler Relat Disord. 2020 Nov;46:102574. doi: 10.1016/j.msard.2020.102574. Epub 2020 Oct 8.

    PMID: 33296972BACKGROUND
  • Huang MH, Fry D, Doyle L, Burnham A, Houston N, Shea K, Smith H, Wiske L, Goode J, Khitrik E, Kolanda M. Effects of inspiratory muscle training in advanced multiple sclerosis. Mult Scler Relat Disord. 2020 Jan;37:101492. doi: 10.1016/j.msard.2019.101492. Epub 2019 Nov 1.

    PMID: 31707233BACKGROUND
  • Inzelberg R, Peleg N, Nisipeanu P, Magadle R, Carasso RL, Weiner P. Inspiratory muscle training and the perception of dyspnea in Parkinson's disease. Can J Neurol Sci. 2005 May;32(2):213-7. doi: 10.1017/s0317167100003991.

    PMID: 16018157BACKGROUND
  • Duman Ozkan T, Oguz S, Unal E, Emir C, Polat MG. Effects of inspiratory muscle training on balance, trunk control, fear of falling, respiratory function, and quality of life in people with multiple sclerosis: a randomized controlled trial. Mult Scler Relat Disord. 2025 Nov;103:106699. doi: 10.1016/j.msard.2025.106699. Epub 2025 Aug 18.

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized Controlled Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

December 29, 2022

First Posted

October 10, 2023

Study Start

March 6, 2023

Primary Completion

February 26, 2024

Study Completion

June 26, 2024

Last Updated

May 6, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

The IPD will not be shared with other researchers.

Locations